{"id":"W4292999428","doi":"10.54097/hset.v8i.1182","title":"T Recent advances of FDA-approved CAR-T therapies in multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Intensive care medicine; Drug; Cytokine release syndrome; Adverse effect; Refractory (planetary science); Cancer; Oncology; Chimeric antigen receptor; Internal medicine; Pharmacology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001842797,0.0005433339,0.0006069382,0.0009264228,0.0003446417,0.001166832,0.0006331528,0.001401022,0.004940388],"category_scores_gemma":[0.001401108,0.0002151742,0.0006201324,0.0009938073,0.0006092998,0.001433746,0.0006017772,0.002391117,0.001788076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007963956,"about_ca_system_score_gemma":0.001245928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008703653,"about_ca_topic_score_gemma":0.001379659,"domain_scores_codex":[0.9996126,0.00008431495,0.00003877199,0.00006552756,0.0001324553,0.00006636272],"domain_scores_gemma":[0.9991964,0.0002578208,0.0001227233,0.00004016572,0.0002517334,0.0001312399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005178886,0.0003083251,0.0008325184,0.00322681,0.00009314444,0.0004121498,0.00009642487,0.0007967348,0.008910923,0.008990603,0.05398969,0.9218248],"study_design_scores_gemma":[0.0001467962,0.0009853066,0.001357779,0.0008092796,0.0001788124,0.001431375,0.0001003557,0.0009774183,0.009529162,0.004060122,0.98039,0.00003351053],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003796336,0.9737607,0.00273203,0.00881462,0.001629127,0.00003043965,0.000134725,0.0001080836,0.008993879],"genre_scores_gemma":[0.03774774,0.9430567,0.003307016,0.007521205,0.003096147,0.00005638164,0.0003417281,0.00002176695,0.00485129],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004940388,"threshold_uncertainty_score":0.01652724,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01480405433815957,"score_gpt":0.2646541526569917,"score_spread":0.2498500983188321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}